Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Pulmonary Hypertension

Free Subscription 20.02.2023 1 Acta Paediatr 3 Ann Rheum Dis 1 Aust N Z J Obstet Gynaecol 1 Basic Clin Pharmacol Toxicol 1 Biomark Med 1 bioRxiv 1 BMC Pulm Med 2 Cardiol Young 1 Cardiovasc Interv Ther 1 Cardiovasc Pathol 1 Chest 1 Circ J 2 Circulation 1 Clin Res Cardiol 1 Curr Probl Cardiol 1 Eur J Med Res 1 Front Cardiovasc Med 1 Front Pediatr 2 Heart 1 Int J Cardiol 2 Int J Mol Sci 2 J Am Coll Cardiol 1 J Am Heart Assoc 1 J Clin Med 1 J Heart Lung Transplant 1 J Pediatr Surg 1 J Thromb Thrombolysis 1 Medicina (B Aires) 1 Open Heart 1 Pediatr Neonatol 1 Perfusion 2 Pulm Circ 1 Rev Med Liege 1 Saudi Med J 1 Scott Med J 1 Transl Pediatr

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Paediatr

1. MULLALY R, McCallion N, El-Khuffash A
   Inhaled nitric oxide in preterm neonates with preterm prelabour rupture of membranes, a systematic review.
   Acta Paediatr. 2022 Nov 15. doi: 10.1111/apa.16596.
   PubMed         Abstract available
   
   

   
   Ann Rheum Dis

2. SANGES S, Rice L, Tu L, Valenzi E, et al
   Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis.
   Ann Rheum Dis. 2023;82:365-373.
   PubMed         Abstract available
   
   
3. IUDICI M, Allali D, Porcher R
   Correspondence on 'Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension'.
   Ann Rheum Dis. 2023;82:e65.
   PubMed        
   
   
4. GRUNIG E, Benjamin N, Xanthouli P, Jordan S, et al
   Response to: ' Correspondence on 'Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension'' by Iudici et al.
   Ann Rheum Dis. 2023;82:e66.
   PubMed        
   
   

   
   Aust N Z J Obstet Gynaecol

5. BOYERS S, Nayyar R, Melov SJ, Tanous D, et al
   A case series describing the multidisciplinary management of pulmonary arterial hypertension in pregnancy: Time for optimism.
   Aust N Z J Obstet Gynaecol. 2022 Jun 14. doi: 10.1111/ajo.13557.
   PubMed         Abstract available
   
   

   
   Basic Clin Pharmacol Toxicol

6. TEIXEIRA-FONSECA JL, de Lima Conceicao MR, Leal-Silva P, Roman-Campos D, et al
   Ranolazine exerts atrial antiarrhythmic effects in a rat model of monocrotaline- induced pulmonary hypertension.
   Basic Clin Pharmacol Toxicol. 2023 Feb 17. doi: 10.1111/bcpt.13845.
   PubMed         Abstract available
   
   

   
   Biomark Med

7. KERANOV S, Widmann L, Jafari L, Liebetrau C, et al
   GDF-15 and soluble ST2 as biomarkers of right ventricular dysfunction in pulmonary hypertension.
   Biomark Med. 2023 Feb 15. doi: 10.2217/bmm-2022-0395.
   PubMed         Abstract available
   
   

   
   bioRxiv

8. PIPER B, Bogamuwa S, Hossain T, Farkas D, et al
   RAB7 deficiency impairs pulmonary artery endothelial function and promotes pulmonary hypertension.
   bioRxiv. 2023 Feb 6:2023.02.03.526842. doi: 10.1101/2023.02.03.526842.
   PubMed         Abstract available
   
   

   
   BMC Pulm Med

9. CHEN W, Luo J, Chen J, Chen Y, et al
   Effect of multidisciplinary team (MDT) centred on pregnant women with pulmonary hypertension on treatment and outcomes of pregnancy.
   BMC Pulm Med. 2023;23:62.
   PubMed         Abstract available
   
   

   
   Cardiol Young

10. TAKATSUKI S, Nakayama T, Shimizu Y, Kawai R, et al
    Clinical efficacy and safety of selexipag in children and young adults with idiopathic and heritable pulmonary arterial hypertension.
    Cardiol Young. 2023;33:196-200.
    PubMed         Abstract available
    
    
11. TAKAFUJI H, Amano H, Obunai K
    Cyanosis in atrial septal defect with prominent crista terminalis.
    Cardiol Young. 2023;33:306-308.
    PubMed         Abstract available
    
    

    
    Cardiovasc Interv Ther

12. YONEYAMA S, Ozaki K, Kubota N, Okubo T, et al
    Efficacy of angioscopy to evaluate guidewire position in mesh formation in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    Cardiovasc Interv Ther. 2023 Feb 15. doi: 10.1007/s12928-023-00916.
    PubMed        
    
    

    
    Cardiovasc Pathol

13. YUAN L, Tang Y, Yin L, Lin X, et al
    The Role of Transmembrane protein 16A (TMEM16A) in Pulmonary hypertension.
    Cardiovasc Pathol. 2023 Feb 11:107525. doi: 10.1016/j.carpath.2023.107525.
    PubMed         Abstract available
    
    

    
    Chest

14. HOWARD LS, Rosenkranz S, Frantz RP, Hemnes AR, et al
    Assessing Daily Life Physical Activity by Actigraphy in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE).
    Chest. 2023;163:407-418.
    PubMed         Abstract available
    
    

    
    Circ J

15. SATO T, Fukui S, Shirota Y, Hasegawa K, et al
    Recovery From Advanced Right Heart Failure Due to Takayasu Arteritis Complicated by Severe Pulmonary Hypertension With Balloon Pulmonary Angioplasty　- Usefulness of Multimodality Imaging.
    Circ J. 2023 Feb 15. doi: 10.1253/circj.CJ-22-0706.
    PubMed        
    
    

    
    Circulation

16. CHIN KM, Santiago-Munoz P
    Pregnancy and Congenital Heart Disease-Associated Pulmonary Hypertension: Are Outcomes Improving?
    Circulation. 2023;147:562-564.
    PubMed        
    
    
17. ZHANG Q, Zhu F, Shi G, Hu C, et al
    Maternal Outcomes Among Pregnant Women With Congenital Heart Disease-Associated Pulmonary Hypertension.
    Circulation. 2023;147:549-561.
    PubMed         Abstract available
    
    

    
    Clin Res Cardiol

18. WIDMANN L, Keranov S, Jafari L, Liebetrau C, et al
    Fibroblast growth factor 23 as a biomarker of right ventricular dysfunction in pulmonary hypertension.
    Clin Res Cardiol. 2023 Feb 15. doi: 10.1007/s00392-023-02162.
    PubMed         Abstract available
    
    

    
    Curr Probl Cardiol

19. TORRES-ROJAS MB, Cueto-Robledo G, Roldan-Valadez E, Navarro-Vergara DI, et al
    Association between the degree of severity of pulmonary hypertension with the presence of pulmonary artery aneurysm: a brief updated review for clinicians.
    Curr Probl Cardiol. 2023 Feb 9:101645. doi: 10.1016/j.cpcardiol.2023.101645.
    PubMed         Abstract available
    
    

    
    Eur J Med Res

20. LI Y, Deng X, Zhou H, Zheng X, et al
    Bile acid predicts congenital portosystemic venous shunt in patients with pulmonary arterial hypertension.
    Eur J Med Res. 2023;28:74.
    PubMed         Abstract available
    
    

    
    Front Cardiovasc Med

21. MAMAZHAKYPOV A, Lother A
    Therapeutic targeting of mineralocorticoid receptors in pulmonary hypertension: Insights from basic research.
    Front Cardiovasc Med. 2023;10:1118516.
    PubMed         Abstract available
    
    

    
    Front Pediatr

22. YOUSSEF DE, Handler SS, Richards SM, Sheppard CA, et al
    Multicenter review of a tadalafil suspension formulation for infants and children with pulmonary hypertension: A North American experience.
    Front Pediatr. 2023;11:1055131.
    PubMed         Abstract available
    
    

    
    Heart

23. MCCORMICK A, Krishnan A, Badesch D, Benza RL, et al
    Pulmonary artery compliance in different forms of pulmonary hypertension.
    Heart. 2023 Feb 14:heartjnl-2022-321760. doi: 10.1136/heartjnl-2022-321760.
    PubMed         Abstract available
    
    
24. EDWARD J, Banchs J, Parker H, Cornwell W, et al
    Right ventricular function across the spectrum of health and disease.
    Heart. 2023;109:349-355.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

25. ZHANG HD, Yan Y, He YY, Liu QQ, et al
    Characteristics of exercise intolerance in different subgroups of pulmonary arterial hypertension associated with congenital heart disease.
    Int J Cardiol. 2023;375:29-35.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

26. PENG Y, Dai J, Zhao YY
    Egln1(Tie2Cre) Mice Exhibit Similar Therapeutic Responses to Sildenafil, Ambrisentan, and Treprostinil as Pulmonary Arterial Hypertension (PAH) Patients, Supporting Egln1(Tie2Cre) Mice as a Useful PAH Model.
    Int J Mol Sci. 2023;24:2391.
    PubMed         Abstract available
    
    
27. GOTEN C, Usui S, Takashima SI, Inoue O, et al
    Important Role of Endogenous Nerve Growth Factor Receptor in the Pathogenesis of Hypoxia-Induced Pulmonary Hypertension in Mice.
    Int J Mol Sci. 2023;24:1868.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

28. FORFIA PR
    Association of Left Ventricular Filling Pressure With Chronic Thromboembolic Pulmonary Hypertension: A Matter of Perspective.
    J Am Coll Cardiol. 2023;81:665-667.
    PubMed        
    
    
29. GERGES C, Pistritto AM, Gerges M, Friewald R, et al
    Left Ventricular Filling Pressure in Chronic Thromboembolic Pulmonary Hypertension.
    J Am Coll Cardiol. 2023;81:653-664.
    PubMed         Abstract available
    
    

    
    J Am Heart Assoc

30. BRAAMS NJ, Kianzad A, Meijboom LJ, Westenberg J, et al
    Right Ventricular Function During Exercise After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension.
    J Am Heart Assoc. 2023 Feb 15:e027638. doi: 10.1161/JAHA.122.027638.
    PubMed         Abstract available
    
    

    
    J Clin Med

31. MANEIRO MELON NM, Velazquez Martin M, Huertas Nieto S, Albarran Gonzalez-Trevilla A, et al
    Effectiveness and Safety of Balloon Pulmonary Angioplasty for the Treatment of Patients with Persistent Pulmonary Hypertension after Pulmonary Endarterectomy.
    J Clin Med. 2023;12:905.
    PubMed         Abstract available
    
    

    
    J Heart Lung Transplant

32. NISHIHARA T, Shimokawahara H, Ogawa A, Naito T, et al
    Comparison of the safety and efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension patients with surgically accessible and inaccessible lesions.
    J Heart Lung Transplant. 2023 Jan 19:S1053-2498(23)00007.
    PubMed         Abstract available
    
    

    
    J Pediatr Surg

33. LICHTSINN K, Waltz PK, Azzuqa A, Church J, et al
    Impact of a standardized management guideline for infants with CDH: A single-center experience.
    J Pediatr Surg. 2022 Aug 1. pii: S0022-3468(22)00499.
    PubMed         Abstract available
    
    

    
    J Thromb Thrombolysis

34. MYLVAGANAM R, Lawrence R, Goldberg I, Rahaghi F, et al
    Differences in referral to a chronic thromboembolic pulmonary hypertension center following acute pulmonary embolism: a locoregional experience.
    J Thromb Thrombolysis. 2023 Feb 12. doi: 10.1007/s11239-023-02781.
    PubMed         Abstract available
    
    

    
    Medicina (B Aires)

35. CIANCIULLI TF, Prieto O, Stewart-Harris A, Rodriguez AS, et al
    Subcostal right ventricular free wall strain in patients with pulmonary hypertension.
    Medicina (B Aires). 2023;83:19-28.
    PubMed         Abstract available
    
    

    
    Open Heart

36. MOONEN A, Ng MKC, Playford D, Strange G, et al
    Atrial functional mitral regurgitation: prevalence, characteristics and outcomes from the National Echo Database of Australia.
    Open Heart. 2023;10:e002180.
    PubMed         Abstract available
    
    

    
    Pediatr Neonatol

37. WU JH, Wang YJ, Liau JY, Lee NC, et al
    Rapid genetic diagnosis of neonatal persistent pulmonary hypertension with a novel FOXF1 mutation.
    Pediatr Neonatol. 2023 Jan 25:S1875-9572(23)00018.
    PubMed        
    
    

    
    Perfusion

38. HAUMANN RG, Buys D, Hofland E, Romijn HW, et al
    A modified perfusion protocol for pulmonary endarterectomy in a patient with a hematologic malignancy treated with a tyrosine kinase inhibitor.
    Perfusion. 2023;38:418-421.
    PubMed         Abstract available
    
    

    
    Pulm Circ

39. RAVNESTAD H, Andersen R, Birkeland S, Svalebjorg M, et al
    Pulmonary endarterectomy and balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: Comparison of changes in hemodynamics and functional capacity.
    Pulm Circ. 2023;13:e12199.
    PubMed         Abstract available
    
    
40. BERNARDO RJ, de Jesus Perez V
    The social and economic disadvantage in pulmonary hypertension: A work (still) in progress.
    Pulm Circ. 2023;13:e12196.
    PubMed        
    
    

    
    Rev Med Liege

41. MALOIR Q, Petitjean H, Parzibut G, Weber T, et al
    [Advances in pulmonary hypertension diagnosis and risk stratification].
    Rev Med Liege. 2023;78:99-106.
    PubMed         Abstract available
    
    

    
    Saudi Med J

42. ALHARBI AH, Alrajhi NA, Alfaris AK, Hawari MR, et al
    Metastatic pancreatic cancer presenting with pulmonary arterial hypertension.
    Saudi Med J. 2023;44:218-222.
    PubMed         Abstract available
    
    

    
    Scott Med J

43. JIANG C, Jiang W
    Lasso algorithm and support vector machine strategy to screen pulmonary arterial hypertension gene diagnostic markers.
    Scott Med J. 2023;68:21-31.
    PubMed         Abstract available
    
    

    
    Transl Pediatr

44. NAKWAN N, Kunhapan P, Chaiyasung T, Satproedprai N, et al
    Genome-wide association study identifies WWC2 as a possible locus associated with persistent pulmonary hypertension of the newborn in the Thai population.
    Transl Pediatr. 2023;12:1-12.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: